ASC30 subcutaneous (SQ) depot formulation achieved statistically significant and clinically meaningful placebo-adjusted mean weight loss of 7.5% at week 16 after three monthly doses.

ITF Therapeutics LLC, the U.S. rare disease affiliate of Italfarmaco, today announced the presentation of ten abstracts at the Muscular Dystrophy Association (MDA) Clinical and Scientific Conference ...

Doctors, nurses, paramedics, and even janitors are privy to things that might surprise even the most hardcore 'Grey's Anatomy ...

Strong capital position of $667.2 million in cash, cash equivalents and short-term investments, together with $180 million in anticipated collaboration payments, expected to support advancement of ...

Have a major deliverable coming up that involves lots of people and tasks? The top project management apps we've tested can help you keep your team on track. I'm an expert in software and work-related ...